On March 22, 2016, the NIH Office of Science Policy published a Federal Register notice detailing the revised procedures for the review of human gene transfer trials subject to the NIH Guidelines for Res
The NIH OSP has recently launched a new listserv that will allow stakeholders to receive timely updates on policy areas including biosafety and biosecurity, clinical research, genomic data sharing, technology transfer, innovation policy, scientific reporting, and much more. The listserv will also provide subscribers with information on upcoming OSP and trans-governmental meetings and work
This annual report captures the extent and nature of activities undertaken by the National Institutes of Health (NIH) in collaboration with other agencies and divisions of the Department of Health and Human Services (HHS).
Mark Your Calendars for These Events of Interest to IBCs and Others - OBA plans to participate in several conferences and events in the upcoming months, giving presentations, staffing exhibits, and conducting training sessions that will offer information about the oversight
The NIH Office of Biotechnology Activities is pleased to announce the availability of the IBC-RMS. The IBC-RMS is a Web-based registration management system that supports the online submission of IBC registrations and annual registration updates.
The NIH Statement Conveying the Concurrence of the HHS Secretary with the Recommendations of the National Science Advisory Board for Biosecurity Regarding Revised Manuscripts on Transmissibility of A/H5N1 Influenza Virus is now available.
The NIH Statement Regarding the Full Recommendations of the National Science Advisory Board for Biosecurity Regarding its March 29-30, 2012 Meeting to Review Revised Manuscripts on Transmissibility of A/H5N1 Influenza Virus is now available.
The purpose of this Policy is to establish regular review of United States Government funded or conducted research with certain high-consequence pathogens and toxins for its potential to be dual use research of concern (DURC) in order to: (a) mitigate risks where appropriate; and (b) collect information needed to inform the development of an updated policy, as needed, for the oversight of DURC.